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Abstract
Background: Trauma patients are at high risk of
developing systemic inflammatory response syndrome
(SIRS) and infections. The aim of this study was to
evaluate the influence of the severity of injury and the
extent of hemorrhagic shock at admission on the
incidence of SIRS, infection and septic complications.
Methods: A total of 972 patients who had an injury
severity score (ISS) of ‡ 17, survived more than 72 h,
and were admitted to a level I trauma center within
24 h after trauma were included in this retrospective
analysis. SIRS, sepsis and infection rates were
measured in patients with different severities of injury as
assessed by ISS, or with various degrees of hemorrhagic
shock according to ATLSguidelines, and were compared
using both uni- and multivariate analysis.
Results: Infection rates and septic complications in-
crease significantly (p < 0.001) with higher ISS. Severe
hemorrhagic shock on admission is associated with a
higher rate of infection (72.8%) and septic complications
(43.2%) compared to mild hemorrhagic shock (43.4%,
p < 0.001 and 21.7%, p < 0.001, respectively).
Conclusions: The severity of injury and the severity of
hemorrhagic shock are risk factors for infectious and
septic complications. Early diagnostic and adequate
therapeutic work up with planned early ‘‘second look’’
interventions in such high-risk patients may help to
reduce these common posttraumatic complications.
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Introduction
Severe traumatic injury leads to a state of systemic
inflammation (systemic inflammatory response syn-
drome, SIRS) followed by a period of recovery medi-
ated by the counter-regulatory anti-inflammatory
response syndrome (CARS) [1, 2]. SIRS promotes a
number of beneficial effects such as the clearance of
pathogenic organisms or the local sequestration of
tissue factors to promote wound healing. Overactiva-
tion of this physiological mechanism, however, may
lead to a dysfunction of vital organs (multiple organ
dysfunction syndrome, MODS) and may ultimately
result in multiple organ failure (MOF) [2, 3]. CARS,
being a counter-regulatory cascade, can ultimately re-
sult in immunosuppression and increased susceptibility
to infection, which may reactivate SIRS, leading to late
MODS [2, 3]. Infections and SIRS are frequently ob-
served problems in severely injured patients [1, 4–9].
Two or more SIRS criteria on admission and persistent
SIRS postinjury were found to be predictive of infec-
tious complications in previous studies, indicating a
marked susceptibility for infection through prolonged
SIRS [9, 10]. A number of studies describe the influ-
ence of hemorrhage on the incidence of infection
and SIRS [5, 11–13]. Peitzman et al. [14] demonstrated
that the presence of hemorrhagic shock increases the
rate of bacterial translocation during hypotension and
also the ischemic disruption of the intestinal mucosal
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barrier, leading to systemic dissemination of intestinal
bacteria. Clinical and experimental studies have shown
that the rate of wound infection is increased after
trauma and hemorrhagic shock [15, 16]. Other studies
have shown that the requirement of blood transfusion
as a surrogate index of hemorrhage is a risk factor for
infection following trauma [8, 17–19]. Papia et al. [8]
demonstrated a dose-dependent relationship between
the number of units of packed red blood cells (PRBC)
transfused and the subsequent incidence of infection.
A recent prospective observational study by Beale
et al. [18] on 120 trauma patients further showed that
transfusion of > 4 units of blood was an independent
risk factor for SIRS.
Similarly, a number of studies have shown that the
ISS is associated with patient outcome following trau-
ma. The ISS was found to be a good predictor of post-
injury MOF, and was further found to be associated
with the development of acute respiratory distress
syndrome (ARDS) [3]. The mortality rate in trauma
patients was reported to increase with higher ISS
scores [20]. Conflicting data are available with respect
to the relationship between ISS and the rate of infec-
tion [4–6, 8, 10]. Pories et al. [5], using a retrospective
analysis of 2,496 patients, demonstrated a significant
relationship between the development of infection and
ISS. Furthermore, infected patients had suffered sig-
nificantly more injuries to the spine, chest, abdominal
and pelvic regions than those without subsequent
infection. In contrast, Hurr et al. [4] failed to find a
relationship between ISS and infection in their retro-
spective chart review of 113 patients. Also, Baker et al.
[6] failed to find a statistically significant association
between injury severity and incidence of pneumonia in
62 intubated trauma patients.
Some studies have indicated that higher ISS scores
may be a risk factor for the development of posttrau-
matic inflammatory complications, such as SIRS [1, 9,
20, 21]. Ertel et al. [21] determined that the severity
of SIRS and the incidence of septic complications
increased significantly with the severity of trauma as
measured by ISS in 1,278 patients.
The aim of the present study was to evaluate the
incidence of SIRS and infections in our database of
severely traumatized patients and to determine whether
an association exists between the ISS score and hemor-
rhagic shock on one side and the development of infec-
tion and SIRS on the other. It is our hypothesis that the
rate of specific, clinical infections is independently asso-
ciated with both the severity of injury as quantified by the
ISS, and the severity of hemorrhage according to the
Advanced Trauma Life Support (ATLS) guidelines.
Patients and Methods
A total of 972 patients admitted to the emergency
department of the University Hospital of Zu¨rich were
enrolled into the present study over a ten-year period.
Admission criteria were an Injury Severity Score (ISS)
‡ 17 and admission to our level I trauma center within
24 h, followed by intensive care treatment and survival
for more than 72 h to evaluate the occurrence of
inflammatory complications. The treatment of all pa-
tients followed ATLS guidelines and the previously
outlined trauma management protocol [22–24].
Briefly, after establishing airway, ventilation and
cardiovascular functions, life-saving procedures
including decompression of body cavities, control of
hemorrhage and contamination were conducted. This
was followed by radical wound debridement, decom-
pression of compartments, and primary stabilization of
major fractures (‘‘day-one surgery’’) [22, 23]. The use of
perioperative prophylactic antibiotics was generally
based on the site and type of injury. All patients re-
ceived enteral nutrition within 24 h following trauma to
maintain normal intestinal flora and mucosa, thereby
reducing or avoiding peritoneal bacterial translocation.
All data were prospectively collected regarding
infection (as defined below), isolated pathogens, ISS,
severity of hemorrhagic shock on admission, time from
injury to admission, and other demographic, clinical
and laboratory parameters. All patient data were re-
trieved following local Institutional Review Board
(IRB) approval according to the University of Zurich
IRB guidelines.
Scoring Systems
The abbreviated injury score (AIS) and ISS were used to
define the severity of injury [25]. The Glasgow Coma Scale
(GCS) and the Acute Physiology and Chronic Health
Evaluation (APACHE) Score were used to quantify
neurologic disability and overall health impairment upon
admission and throughout the hospital stay [26, 27].
Definition of Hemorrhagic Shock
The severity of hemorrhagic shock was defined
according to the guidelines of the ATLS [28]. The
patients were subdivided into four classes with class I
and II as uncomplicated hemorrhage and a blood vol-
ume loss of up to 15 and 15–30%, respectively. Class III
is a complicated hemorrhagic state with 30–40% blood
volume loss. The degree of exsanguination in class IV
hemorrhage is immediately life-threatening, with more
than 40% blood volume loss [28]. For this study, we
defined classes I and II as mild hemorrhage and classes
III and IV as severe hemorrhage.
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Definition of SIRS
Systemic inflammatory response syndrome and sepsis
were defined according to the guidelines of the
American College of Chest Physicians/Society of
Critical Care Medicine Consensus Conference, but
modified in that these criteria had to be fulfilled for at
least three continuous days to confirm the presence of
SIRS or sepsis [1, 29]. SIRS was subdivided into four
different grades (two positive SIRS criteria = SIRS 2,
three positive SIRS criteria = SIRS 3, four positive
SIRS criteria = SIRS 4). Sepsis was diagnosed if all
criteria of SIRS (SIRS 4) were fulfilled for at least
three days in combination with a proven infectious
focus or positive blood cultures [1].
Diagnosis of Infection
Surveillance for infection was performed by intensive
care physicians and institutional infectious disease
specialists. Cultures were taken on admission and
regularly during the ICU stay from sputum, tracheo-
bronchial aspirate, wound exudates and urine. Blood
and intravascular catheter tip cultures were taken
when central venous catheter (CVC)-related infection
and/or bacteremia was suspected. Diagnosis of infec-
tion was based on modified Center for Disease Control
and Prevention (CDC) definitions of nosocomial and
surgical site infection with the following modifications:
CVC infection was defined as local signs of infection, a
positive catheter tip culture but negative blood cultures
[30]; bacteremia was defined as at least one positive
blood culture with clinical findings (two or more SIRS
criteria) for which antimicrobial therapy had to be
initiated. Primary bloodstream infections (no focus of
infection) and secondary bloodstream infections (with
a focus of infection) were combined into this group.
Pneumonia was diagnosed by the presence of a new or
changing infiltrate on chest X-ray as well as clinical
(two or more SIRS criteria) and laboratory findings.
Wounds were considered to be infected in the presence
of purulent exudates requiring surgical wound care.
Statistical Analysis
Continuous data are provided as mean ± standard
deviation (SD) and compared between groups using
the Mann–Whitney test and the Kruskal–Wallis test.
Categorical data are presented as numbers with per-
centages and are compared using Pearson’s chi-square
test. Differences are considered significant at p < 0.05.
Multiple logistic regressions were performed to assess
the impact of ISS and degree of hemorrhagic shock on
infection and sepsis. In this case, ISS and degree of
hemorrhagic shock were analyzed as continuous and
categorical variables, respectively. All statistical anal-
yses were performed using the SPSS software package
(SPSS 13.0, SPSS Inc., Chicago, IL, USA).
Results
Patient Collective
A total of 972 trauma patients were included in this
study (Table 1). The majority of injuries were the re-
sult of blunt trauma (n = 888, 91.4%). Intensive care
unit (ICU) stay was 13.5 ± 11.7 days and the mean
length of hospital stay was 25.5 ± 18.9 days. Overall
mortality in the entire study population was 10.5%
(n = 102).
Infection Rate
An infection was diagnosed in 446 patients (45.9%),
with a mean time to infection of 11.3 ± 9.9 days.
Table 1. Patient collective. (ISS: Injury Severity Score; GCS: Glasgow Coma Scale; APACHE II: Acute Physiology and Chronic Health Evaluation II;
ICU: intensive care unit).
Characteristics All patients Infected patients Noninfected patients p value
Number (% of total) 972 446 (45.9) 526 (54.1)
Age (years)a 40.2 ± 17.0 40.6 ± 16.7 39.9 ± 17.3 ns
Males (% of males) 746 349 (46.7) 397 (53.3) ns
Females (% of females) 226 97 (42.9) 129 (57.1) ns
ISS (points)a 31.9 ± 10.9 34.3 ± 11.7 29.9 ± 9.8 < 0.001b
GCS (points)a 8.6 ± 5.5 7.5 ± 5.3 9.6 ± 5.5 < 0.001b
APACHE II (points)a 14.5 ± 7.8 16.8 ± 7.5 12.6 ± 7.5 < 0.001b
ICU (days)a 13.5 ± 11.8 20.8 ± 12.9 7.3 ± 5.4 < 0.001b
Mortality 102 (10.5) 60 (13.5) 42 (8.0) 0.006c
aMean ± SD. Values in parentheses are percentages
bMann–Whitney test
cPearson chi-square test
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Patients developing posttraumatic infections had sig-
nificantly higher ISS and APACHE II scores and sig-
nificantly lower GCS scores than noninfected patients
(p < 0.001). Also, ICU length of stay and mortality
were significantly increased in infected patients com-
pared to the noninfected group. In contrast, age and
gender did not have any significant influence on the
infection rate (Table 1).
Sites of Infection
The sites of infection and the most commonly isolated
microorganisms are summarized in Table 2. The most
frequent type of infection was pneumonia (34.3%),
followed by bacteremia (14.7%), wound infections
(13.4%), catheter-related infections (11.4%), and uri-
nary tract infections (9.0%). Primary bloodstream
infections (n = 45) occured in 35.7% of cases. The foci
of secondary bloodstream infections (n = 81, 64.3%)
were mainly catheter infections (n = 40, 49.4%),
pneumonia (n = 24, 29.6%), and central nervous
system (CNS) infection (n = 6, 7.4%). 48.9% of the
isolated microorganisms were Gram-positive, 49.3%
Gram-negative, 1.7% were fungi, and 0.1% were
viruses. The most commonly recovered pathogens
included Staphylococcus aureus (n = 176, 15.5%),
coagulase-negative staphylococci (CNS, n = 162,
14.3%), Pseudomonas aeruginosa (n = 115, 10.1%),
Enterococcus spp. (n = 113, 10.0%), Escherichia coli
(n = 104, 9.2%), and Enterobacter spp. (n = 94, 8.3%).
Incidence of SIRS, Bacteremia and Sepsis
Table 3 shows the incidence of systemic inflammation
SIRS and a comparison of SIRS criteria between in-
fected and noninfected patients. SIRS ‡ 2 was present
in 81.9% (n = 796) of all included patients, most of
whom had SIRS 3 or 4. 228 (51.1%) of all infected
patients developed 234 septic episodes, the majority of
which were associated with pneumonia (n = 120,
51.3%), bacteremia (i.e., positive blood culture; n = 30,
12.8%), wound infection (n = 20, 8.5%), catheter-re-
lated infection (n = 12, 5.1%) or intracranial infection
(n = 12, 5.1%).
Influence of ISS on Incidence of Infection, SIRS and
Sepsis
The associations between ISS and infection, SIRS and
sepsis are shown in Figures 1 and 2 using different ISS
groups. ISS scores significantly predicted the overall
infection rate (p < 0.001; Table 1; Figure 1). The per-
centage of patients with low systemic inflammation (no
Table 2. Main types of infections and predominant microorganisms.
Infection N infections (% of total) Predominant microorganism (% of subgroup)
Pneumonia 294 (34.3) Staphylococcus aureus (13.2)
Ha¨mophilus spp. (8.9)
Pseudomonas aeruginosa (7.7)
Bacteremia 126 (14.7) Coagulase-negative staphylococci (24.9)
Staphylococcus aureus (11.2)
Wound infection 115 (13.4) Enterococcus spp. (12.5)
Bacillus cereus (12.5)
Coagulase-negative staphylococci (12.1)
Catheter infection 98 (11.4) Coagulase-negative staphylococci (33.9)
Enterobacter spp. (8.9)
Staphylococcus aureus (8.9)
Urinary tract infection 77 (9.0) Escherichia coli (35.6)
Enterococcus spp. (21.8)
CNS infection 56 (6.5) Coagulase-negative staphylococci (31)
Enterococcus spp. (14.3)
Intra-abdominal infection 28 (3.3) Enterococcus spp. (24.2)
Coagulase-negative staphylococci (12.1)
Bone or joint infection 12 (1.4) Enterococcus spp. (11.8)
Coagulase-negative staphylococci (11.8)
Othera or unknown infection site 51 (6.0) Clostridium difficile (33.3)
Candida albicans (25)
aOther sites of infection include Clostridium difficile-associated colitis (n = 8), esophagitis and oral candidiasis (n = 4), thoracic infections (pericarditis
and pleural empyema) (n = 4), soft tissue infections (myositis, fasciitis, parotitis) (n = 5), genital tract infections (vaginitis, colpitis) (n = 3), infected
hematoma (n = 2) and eye infections (keratitis, conjunctivitis) (n = 2). Infection site unknown (n = 23). CNS: central nervous system.
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SIRS, SIRS 2) was lower in patients with increasing
ISSs (p < 0.001). In patients with low (< 2) SIRS,
moderately injured patients (ISS 17–19) accounted for
52% of patients, whereas more severely injured pa-
tients (e.g., ISS 50–75) accounted for only 10.9%. The
incidence of SIRS 3/4 did not show a similar distribu-
tion. However, the rate of septic complications signif-
icantly increased with increasing ISS scores (p < 0.001;
Figure 2).
Influence of Hemorrhagic Shock on Incidence
of Infection, SIRS and Sepsis
Mild hemorrhagic shock (class I and II) on admission
was present in 891 patients (91.7%), whereas 81 pa-
tients (8.3%) suffered from severe hemorrhagic shock
(class III and IV). ISS scores were significantly related
to the severity of hemorrhagic shock, ranging from
29.9 ± 9.7 points in class I to 40.9 ± 14.2 points in class
IV (p < 0.001; Table 4). Class I and II hemorrhage
were associated with infection rates of 39.7 and 50.5%,
respectively, whereas significantly higher infection
rates were observed in patients with severe hemor-
rhagic shock (class III, 69.6%; class IV, 80.0%;
p < 0.001). This was also evident in the relative accu-
mulation of infectious foci depending on the severity of
hemorrhage (Table 4; Figure 3). A significant increaseFigure 1. Influence of injury severity score (ISS) on the incidence of
infection. Incidence of infection in patients with ISS ‡ 17 points for
different ISS groups. Data represent percentages.
Figure 2. Influence of injury severity score (ISS) on incidence of SIRS
and sepsis. Incidence of SIRS and sepsis in patients with ISS ‡ 17
points for different ISS groups. Data represent percentages. SIRS,
systemic inflammatory response syndrome.
Table 3. Incidence of systemic inflammatory response syndrome (SIRS).
All patients (n = 972) Infected patients (n = 446) Noninfected patients (n = 526) p value
No SIRS 176 (18.1) 16 (3.6) 160 (30.4) < 0.001a
SIRS 2 187 (19.2) 32 (7.2) 155 (29.5) < 0.001a
SIRS 3 and 4 381 (39.2) 170 (38.1) 211 (40.1) ns
Sepsis 228 (23.5) 228 (51.1) 0 (0)b
Values in parentheses are percentages
aPearson chi-square test
bBy definition
Figure 3. Influence of hemorrhagic shock on incidence of infection.
Incidence of infection in patients with ISS ‡ 17 points for the dif-
ferent hemorrhagic shock groups (according to ATLS). Data repre-
sent percentages.
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in septic complications was found with more severe
hemorrhagic shock (class I, 16.5%; class II, 31.4%;
class III, 41.1%; class IV, 48.0%, p < 0.001; Figure 4).
Multiple logistic regression analysis showed that
ISS and the degree of hemorrhagic shock were inde-
pendent risk factors for infection as well as sepsis (all
p < 0.001).
Discussion
The activation of the inflammatory response following
trauma depends on the severity of trauma and on the
individual patient’s physiological condition [3]. The
extent and duration of early SIRS depends on the
magnitude of the initial traumatic load [3]. Within this
inflammatory process, a fine balance exists between the
beneficial effects of local and systemic inflammation
and the potential to cause and aggravate tissue injury
leading to MOF [2]. Negative feedback mechanisms
(CARS) downregulate SIRS to limit this potentially
autodestructive inflammation, resulting in a state of
delayed immunosuppression [2, 3]. During CARS,
subsequent infection represents an important cause of
mortality in patients who initially survive severe trau-
ma but later develop sepsis and late MODS [6].
Recent investigations using modern microarray-
based technology suggest that CARS may further be
promoted by the specific depression of genes respon-
sible for the transcription of proinflammatory cytokines
such as TNF-a, IL-1b, or chemokines such as IL-8. This
genetic reprogramming or ‘‘silencing’’ may develop
rapidly (3–5 h) after the initial activation phase that
generates the overexpression of proinflammatory
cytokines [31]. In addition, the absolute concentrations
of pro- and anti-inflammatory cytokines are influenced
by polymorphisms in cytokine genes, which in the cases
of TNF-a and TNF-b have been shown to affect mor-
tality in sepsis patients [32]. Currently, high-throughput
genomic studies are being performed to analyze
inflammatory leukocyte gene expression patterns on a
genome-wide basis, such as by investigators of the Glue
Grant Consortium [33].
Table 4. Influence of hemorrhagic shock on the incidence of infection and SIRS/sepsis. (ISS: Injury Severity Score; APACHE II: Acute Physiology
and Chronic Health Evaluation II; SIRS: systemic inflammatory response syndrome).
Hemorrhagic shock class I II III IV p value
Number 582 (59.9) 309 (31.8) 56 (5.8) 25 (2.5)
ISS (points)a 29.9 ± 9.7 34.3 ± 11.8 36.1 ± 10.9 40.9 ± 14.2 < 0.001b
APACHE II (points)a 13.1 ± 7.1 15.3 ± 7.5 19.9 ± 9.3 26.0 ± 7.6 < 0.001b
Infected patients 231 (39.7) 156 (50.5) 39 (69.6) 20 (80.0) < 0.001c
Pneumonia 146 (25.1) 99 (32.0) 22 (39.3) 11 (44.0) 0.01c
Wound infection 40 (6.9) 39 (12.6) 14 (25.0) 11 (44.0) < 0.001c
Bacteremia 57 (9.8) 43 (13.9) 13 (23.2) 8 (32.0) < 0.001C
CNS infection 32 (5.5) 18 (5.8) 3 (5.4) 1 (4.0) ns
Catheter infection 40 (6.9) 37 (12.0) 13 (23.2) 6 (24.0) < 0.001c
No SIRS 133 (22.9) 41 (13.2) 2 (3.6) 0 (0) ns
SIRS 2 126 (21.6) 50 (16.2) 9 (16.0) 2 (8.0) ns
SIRS 3 and 4 227 (39.0) 121 (39.2) 22 (39.3) 11 (44.0) < 0.001c
Sepsis 96 (16.5) 97 (31.4) 23 (41.1) 12 (48.0) < 0.001c
Mortality 60 (10.3) 27 (8.7) 11 (19.6) 4 (16.0) ns
aMean ± SD. Values in parentheses are percentages
bKruskal–Wallis test
cPearson chi-square test
Figure 4. Influence of hemorrhagic shock on the incidence of SIRS
and sepsis. Incidence of SIRS and sepsis in patients with ISS ‡ 17
points for the different hemorrhagic shock groups (according to
ATLS). Data represent percentages. SIRS, systemic inflammatory
response syndrome.
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Several other studies have demonstrated high
infection rates in the posttraumatic course of severely
traumatized patients. Papia et al. and Bochiccio et al.
reported overall infection rates in trauma ICU patients
of 37% (mean ISS 24 pts, range 1–75 pts) and 41.3%
(mean ISS 23 ± 12 pts), respectively [8, 9]. Appelgren
et al. [7] found that almost 50% of trauma patients
eventually developed infections. Early recognition of
risk factors for subsequent infection in this group of
high-risk patients may therefore reduce mortality by
allowing early initiation of preventive surgical and
antibiotic measures.
The most common infectious complication ob-
served in our trauma patient population was pneumo-
nia, followed by bacteremia, wound infection, catheter
infection and urinary tract infection. The rates and foci
of infections were in general accordance with the results
of previous studies, even though nosocomial infection
rates from different ICUs are difficult to compare
because of varying study populations, surveillance
methods and different diagnostic criteria. Obviously, the
high rate of respiratory tract infections is a consequence
of frequent ventilator support in trauma patients.
With respect to isolated microorganisms, results
vary by nature in studies from different institutions.
However, the distribution of organisms isolated at our
department was similar to that reported by Papia et al.
[8]. In their study, S. aureus (19%), E. coli (16%) and
P. aeruginosa (10%) were the most commonly recov-
ered pathogens. Again, S. aureus remains the most
frequently observed pathogen, and has been partially
responsible for most kinds of localized infections in our
patient collective, except maybe in the urinary tract.
The ISS is the scoring system most widely used to
quantify the extent of injury in a specific patient [25].
Several studies have examined the predictive value of
the ISS as a risk factor for infection [4–6, 8, 10]. While
most of these demonstrated a significant association
between ISS and infection, a few failed to find such a
relationship [4, 6, 27]. Croce et al. [11] reported that
the ISS was a predictor of abdominal septic compli-
cations in a subset of patients with penetrating
abdominal trauma. Papia et al. [8] found that infected
patients tended to have more severe or extensive
injuries, as demonstrated by a mean ISS of 30 com-
pared with a mean ISS of 21 in noninfected patients
(p < 0.01). Heckbert et al. [13] reported a statistically
significant relationship between ISS in patients with
hypotension and infection. On the other hand, Hurr
et al. [4] failed to verify that ISS was an independent
predictor of nosocomial infections in his study of 113
severely injured patients. In this report, only the length
of ICU stay independently predicted the occurrence of
subsequent nosocomial infections. However, the inci-
dence of infection in our collective was higher with
increasing ISS.
Systemic inflammation is common during the
posttraumatic period and correlates well with the
severity of injury [9, 20, 21, 34]. We have previously
demonstrated that the ISS represents a potent risk
factor for SIRS 3/4 and sepsis in trauma patients [34]. In
a retrospective study of 1,273 patients, ISS and severe
(AIS ‡ 3 pts) head injuries were potent independent
risk factors for SIRS 3/4, MODS and death. With re-
spect to the site of injury, patients with isolated
abdominal and pelvic injuries had the highest rates of
septic complications. In the present study, we did not
assess the influence of different anatomic regions or
injury patterns, but we could again demonstrate that the
incidence of sepsis significantly correlates with the ISS.
Several authors have examined the association
between hypotension (defined as a systolic blood
pressure below 90 mmHg) on admission and infection
[5, 11–13, 16]. Patients who were hypotensive upon
admission were generally more likely to develop hos-
pital-acquired pneumonia, wound infection and bac-
teremia than normotensive patients [5, 7, 12, 13, 16].
Several trials have reported a depression of both the
innate and acquired immune system as a result of acute
hemorrhage causing an increased susceptibility to
infection, SIRS and sepsis in affected patients [15, 35].
Angele et al. demonstrated that wound exudate cells
harvested on the first and third postoperative days
from hemorrhaged animals exhibit an impaired release
of proinflammatory cytokines and chemokines such as
IL-1b and IL-6 in response to a second stimulus
(lipopolysaccharide, LPS) in vitro [15]. They concluded
that this dysfunction of wound exsudate cells could
provide a potential mechanism by which to explain the
impaired bacterial resistance in wounds of trauma pa-
tients, resulting in a higher rate of wound infections.
Other clinical studies found only a weak association
between shock and infection, but a strong correlation
between blood transfusions on admission and sub-
sequent infection, especially pneumonia [11]. There-
fore, the recent trauma literature has focused
extensively on blood transfusion and adverse outcome
in trauma. In a study by Heckbert et al. [13], the
requirement for large volumes of intravenous fluid as a
surrogate index of hemorrhagic shock was associated
with an increased risk of infection, organ failure and
death. Edna et al. [17] demonstrated, in a prospective
study in 868 patients with acute injuries, an obvious
relationship between blood transfusions and infectious
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morbidity independent of ISS, age, and surgical pro-
cedure. They found a corrected odds ratio for infection
of 1.6 when 1–4 units of blood were given and 6.4 when
more than four units were used. Papia et al. [8] dem-
onstrated a dose-dependent relationship between
number of units transfused and risk of infection, with
an odds ratio of 7.71 when more than ten units of blood
were transfused. Beale et al. [18] identified, in a
previous prospective study of 120 patients, that multi-
ple transfusions (> 4 units) are a risk factor for the
development of posttraumatic SIRS. Higher transfu-
sion volumes were also associated with a trend towards
a higher rate of septic complications and organ failure,
although this failed to reach statistical significance. The
association between blood transfusion and risk for
SIRS was also the focus of a study by Malone et al.
performed in 9,569 trauma patients. Patients who re-
ceived blood transfusions had a three- to fivefold in-
creased risk for SIRS and a tenfold increased risk for
mortality. In a subsequent study in a larger cohort of
trauma patients (n = 15,534), the same authors con-
firmed that blood transfusion was a strong independent
predictor of SIRS. SIRS was present in 28% of patients
who underwent blood transfusion within the first 24 h
compared to 15% of patients without transfusion
(p < 0.001) [19]. Potential reasons for higher rates of
infection and SIRS in patients receiving blood trans-
fusions include contaminating leucocytes and inflam-
matory mediators within red blood cell units [36, 37]. A
large body of evidence from animal and ex vivo labo-
ratory studies supports a shift towards a Th2-type im-
mune response with increased levels of IL-4 and IL-10,
and at the same time diminished levels of IL-2, IL-12
or interferon-c. Combined, these changes lead to an
impaired proinflammatory response to bacterial endo-
toxins and affect monocyte function such as phagocy-
tosis or killing of microorganisms [37, 38]. However,
the potential benefits of leukoreduced red cell trans-
fusions remain intensely debated [39, 40].
Fewer reports exist on the use of the hemorrhagic
shock classification according to ATLS criteria as a
predictor of infection in severely injured patients. In
our patient collective, 80% of patients with class IV
hemorrhage did develop infectious complications and
48% developed septic complications. Frequently ob-
served infections in class IV hemorrhage were pneu-
monia and wound infections. To the authors’
knowledge, a detailed analysis of the influence of the
different ATLS shock grades on infection and SIRS
has not yet been reported. The results of our study,
therefore, support the relevance of hemorrhagic shock
on the incidence of infection and SIRS in patients with
significant hemorrhage. In addition, ATLS criteria for
the severity of hemorrhage are simple to use in clinical
practice, providing an excellent tool for rapid assessment
of the severity of hemorrhage in acutely injured patients.
In summary, our data show a distinct relationship
between the severity of injury, the extent of hemor-
rhage, and the subsequent incidence of posttraumatic
infections. It emphasizes timely and adequate resusci-
tation not only to restore patient physiology and min-
imize day-one mortality, but also to reduce long-term
infectious morbidity in trauma patients.
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